Schedule 13D ownership disclosure
Vera Therapeutics Inc
Security class unavailable · CUSIP: 92337R101
Event date: 2024-03-22
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,793,987
- Percent of class
- 5.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-039188
- Form type
- SC 13D
- Filer
- Sofinnova Venture Partners X, L.P.
- CIK
- CIK 1680200
- Filed
- Mar 26, 2024
- Reporting period
- Mar 22, 2024
- Description
- Schedule 13D beneficial ownership